> Details

Isaacs, John D.; Brockbank, Sarah; Pedersen, Ayako Wakatsuki; Hilkens, Catharien; Anderson, Amy; Stocks, Philip; Lendrem, Dennis; Tarn, Jessica; Smith, Graham R.; Allen, Ben; Casement, John; Diboll, Julie; Harry, Rachel; Cooles, Faye A. H.; Cope, Andrew P.; Simpson, Gemma; Toward, Ruth; Noble, Hayley; Parke, Angela; Wu, Wing; Clarke, Fiona; Scott, David; Scott, Ian C.; Galloway, James; [...]

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
  • Contributor: Isaacs, John D.; Brockbank, Sarah; Pedersen, Ayako Wakatsuki; Hilkens, Catharien; Anderson, Amy; Stocks, Philip; Lendrem, Dennis; Tarn, Jessica; Smith, Graham R.; Allen, Ben; Casement, John; Diboll, Julie; Harry, Rachel; Cooles, Faye A. H.; Cope, Andrew P.; Simpson, Gemma; Toward, Ruth; Noble, Hayley; Parke, Angela; Wu, Wing; Clarke, Fiona; Scott, David; Scott, Ian C.; Galloway, James; [...]
  • Published: Springer Science and Business Media LLC, 2022
  • Published in: Scientific Data, 9 (2022) 1
  • Language: English
  • DOI: 10.1038/s41597-022-01264-y
  • ISSN: 2052-4463
  • Origination:
  • Footnote:
  • Description: AbstractRheumatoid arthritis (RA) is a chronic inflammatory disorder with poorly defined aetiology characterised by synovial inflammation with variable disease severity and drug responsiveness. To investigate the peripheral blood immune cell landscape of early, drug naive RA, we performed comprehensive clinical and molecular profiling of 267 RA patients and 52 healthy vaccine recipients for up to 18 months to establish a high quality sample biobank including plasma, serum, peripheral blood cells, urine, genomic DNA, RNA from whole blood, lymphocyte and monocyte subsets. We have performed extensive multi-omic immune phenotyping, including genomic, metabolomic, proteomic, transcriptomic and autoantibody profiling. We anticipate that these detailed clinical and molecular data will serve as a fundamental resource offering insights into immune-mediated disease pathogenesis, progression and therapeutic response, ultimately contributing to the development and application of targeted therapies for RA.
  • Access State: Open Access